Prostate Cancer
Fibroblast growth factor 17 over-expressed in prostate cancer
Published in Gene Therapy Weekly, March 3rd, 2005
"Over-expression of fibroblast growth factor 8 (FGF8) in human prostate cancer is associated with clinically aggressive disease. Among different members of the FGF family, FGF17 and FGF8 share high sequence homology and have similar patterns of expression during embryogenesis.
"In this study, the clinical significance of FGF17 expression and its in vitro function in prostate cancer cells were tested," wrote investigators in England.
"Forty resected prostate specimens from patients with benign prostatic hyperplasia (BPH, n=12) and prostate cancer (CaP, n=28; Gleason...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-03-03)
More Articles from Gene Therapy Weekly
- Anthrax Risk Factors
Host ARAP3 production makes cells vulnerable to anthrax toxin - Brain Cancer
The attenuated adenovirus ONYX-015 fights glioma proliferation - Cancer Therapy
Fusion transgene elicits a robust immunological response to tumor cells - Gene Transfer
Gene transduction corrects cells from patients with Wiskott-Aldrich syndrome - Genetic Engineering
Genetically modified cytolytic T cells recognize and kill glioblastoma - Acute Myeloid Leukemia
XPD genetic variation predicts treatment outcome and AML risk after chemotherapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
